The Familial Hypercholesterolemia (FH) Array offers rapid and reliable assessment of patients with suspected FH. Utilizing Biochip Array Technology, the FH Array offers simultaneous detection of mutations within the LDLR, ApoB and PCSK9 genes. Familial Hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism. It is characterized by high levels of low density lipoprotein (LDL) and early onset of cardiovascular disease. Three main genes which are known to cause FH are low density lipoprotein receptor gene (LDLR), apolipoprotein B (ApoB) and proprotein convertase subtilisin/kexin-type 9 (PCSK9). Key Benefits Include • Easy to interpret results using the Evidence Investigator • Rapid turnaround time • Streamlined workflow - protocol and reagents optimized for the molecular la...Read more
Receive your quote directly from Randox Laboratories Ltd..